Addressing inadequacies in the implementation of existing evidence-based approaches into practice, such as injectable opioid agonist treatment (iOAT), is imperative for the management of opioid use disorder. With the expansion of iOAT, stakeholder perspectives are needed to inform program optimization.
This study aimed to understand stakeholder and provider perspectives on iOAT care and how it can be improved to better meet service users’ needs.